The goal of this Gather-ed experience is to summarize the latest clinical evidence and recommendations for early diagnosis and aggressive management of MS. This initiative consists of self-study modules and live group discussions that briefly review relevant clinical trial findings and addresses questions clinicians commonly face in their practice.
This self-assessment will establish a baseline of your understanding of MS. It will assess your ability to diagnose patients with MS, individualize disease-modifying therapy (DMT), and switch treatment if disease progression is observed.
In this first module, we describe a patient vignette to spearhead a discussion on the diagnostic criteria for MS, including recent data with respect to the potential role of neurofilament as an MS biomarker.
This second module focuses on the current clinical trial findings and real-world data regarding the long-term efficacy and safety of DMT for MS.
In this third module, we outline best-practice recommendations for monitoring disease progression and switching DMT when appropriate. In addition, we describe a case scenario to illustrate the practical application of these principles.
This self-assessment will examine whether you improved your knowledge and competence with respect to MS diagnosis and management following completion of the 3 self-study modules.
This live discussion will offer an interactive approach to providing optimal care to patients with MS. Topics discussed will include diagnosis and referral, available medical therapies, and patient-specific treatment selection.
This live discussion will focus on reviewing the patient case and group tasks and how the findings can apply to caring for current or future patients with MS. We will discuss the submitted tasks and any challenges or clinical controversies associated with these findings.
This group task will focus on the differential diagnosis of suspected MS.
This group task will focus on the management of a patient with RRMS.